Novartis AG NOV.N-CH:Swiss Exchange
*Data is delayed | Exchange | CHF
Last | 5:35 PM CEST
113.52
+0.52 (+0.46%)
+0.52 (+0.46%)Volume
2,862,812
52 week range
91.20 - 131.00
- Open112.54
- Day High114.22
- Day Low111.48
- Prev Close113.00
- 52 Week High131.00
- 52 Week High Date02/27/26
- 52 Week Low91.20
- 52 Week Low Date07/21/25
Latest On Novartis AG
- Novartis CEO on Q1 earnings miss
CNBC.com
Key Stats
- Market Cap230.993B
- Shares Out2.03B
- 10 Day Average Volume2.79M
- Dividend3.70
- Dividend Yield3.26%
- Beta0.82
Latest On Novartis AG
- Novartis CEO on Q1 earnings missCNBC.com
KEY STATS
- Open112.54
- Day High114.22
- Day Low111.48
- Prev Close113.00
- 52 Week High131.00
- 52 Week High Date02/27/26
- 52 Week Low91.20
- 52 Week Low Date07/21/25
- Market Cap230.993B
- Shares Out2.03B
- 10 Day Average Volume2.79M
- Dividend3.70
- Dividend Yield3.26%
- Beta0.82
RATIOS/PROFITABILITY
- EPS (TTM)5.58
- P/E (TTM)20.34
- Fwd P/E (NTM)-
- EBITDA (TTM)18.237B
- ROE (TTM)35.21%
- Revenue (TTM)44.245B
- Gross Margin (TTM)75.41%
- Net Margin (TTM)24.02%
- Debt To Equity (MRQ)121.66%
EVENTS
- Earnings Date-
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORENovartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided...
Giovanni Caforio M.D.
Non-Executive Independent Chairman of the Board
Vasant Narasimhan M.D.
Chief Executive Officer, Member of the Executive Committee
Mukul Mehta
Chief Financial Officer, Member of the Executive Committee
Address
Lichtstrasse 35
Basel
4056
Switzerland